Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. 2009

Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
1st Department of Internal Medicine, Medical Faculty, Pavol Jozef Sáfarik University, Kosice, Slovakia.

Chronic autoimmune thyroiditis (ATD) frequently overlaps with autoimmune rheumatic diseases. The aim of this study was to evaluate the prevalence of various non-organ-specific autoantibodies in patients with ATD, as well as the presence of ATD in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). METHODS Group 1 comprised 80 patients with ATD, and group 2 contained 80 patients with SLE or RA. A control group consisted of 34 healthy subjects. Group 1 was examined for the presence of non-organ-specific autoantibodies. Serum fT3, fT4, TSH, and antibodies against thyroglobulin, thyroperoxidase, as well as ultrasound of thyroid gland, were determined in group 2. RESULTS Patients with ATD had a significantly higher prevalence of antinuclear antibodies (ANA) than control subjects (45% vs. 14.7%, P < 0.001). There were no significant differences in the prevalence of other antibodies between the groups. ANA-positive patients were younger than ANA-negative ones and had significantly higher anti-TG values (P < 0.05). The prevalence of ATD in group 2 was significantly higher than in the control subjects (24% vs. 8%, P < 0.05). No significant differences in the prevalence of ATD were detected between SLE and RA. CONCLUSIONS The authors conclude that ANA is the most frequent non-organ-specific antibody associated with ATD, while the other antibodies occur rarely. The prevalence of ATD in SLE and RA patients was 24%. These results indicate that it is clinically important to screen patients with SLE and RA for the coexistence of thyroid autoimmune disease.

UI MeSH Term Description Entries
D007453 Iodide Peroxidase A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8. Iodinase,Iodothyronine 5'-Deiodinase,Iodothyronine Deiodinase,Iodotyrosine Deiodase,Thyroid Peroxidase,Thyroxine 5'-Deiodinase,Thyroxine 5'-Monodeiodinase,5'-Deiodinase,Deiodinase,Iodotyrosine Deiodinase,Monodeiodinase,Reverse Triiodothyronine 5'-Deiodinase,T4-5'-Deiodinase,T4-Monodeiodinase,Tetraiodothyronine 5'-Deiodinase,Thyroxine Converting Enzyme,Triiodothyronine Deiodinase,5' Deiodinase,5'-Deiodinase, Iodothyronine,5'-Deiodinase, Reverse Triiodothyronine,5'-Deiodinase, Tetraiodothyronine,5'-Deiodinase, Thyroxine,5'-Monodeiodinase, Thyroxine,Deiodase, Iodotyrosine,Deiodinase, Iodothyronine,Deiodinase, Iodotyrosine,Deiodinase, Triiodothyronine,Enzyme, Thyroxine Converting,Iodothyronine 5' Deiodinase,Peroxidase, Iodide,Peroxidase, Thyroid,Reverse Triiodothyronine 5' Deiodinase,T4 5' Deiodinase,T4 Monodeiodinase,Tetraiodothyronine 5' Deiodinase,Thyroxine 5' Deiodinase,Thyroxine 5' Monodeiodinase,Triiodothyronine 5'-Deiodinase, Reverse
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
October 2005, Srpski arhiv za celokupno lekarstvo,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
January 2015, Autoimmunity reviews,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
January 2018, Bratislavske lekarske listy,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
June 2012, The Journal of rheumatology,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
May 2022, The Journal of clinical endocrinology and metabolism,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
July 2019, Clinical rheumatology,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
February 1994, European journal of endocrinology,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
December 1989, Seminars in arthritis and rheumatism,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
January 2012, Revista brasileira de reumatologia,
Ivica Lazúrová, and Karim Benhatchi, and Jozef Rovenský, and Darina Kozáková, and Hedviga Wagnerová, and Mária Tajtáková, and Yehuda Shoenfeld, and Z Macejova
January 2018, Medical principles and practice : international journal of the Kuwait University, Health Science Centre,
Copied contents to your clipboard!